Short and Medium-term Efficacy and Safety of “Sinotech+” (Uzbekistan) Stent in Primary Stenting for Patients with Acute Coronary Syndrome with ST-Segment Elevation

Фозилов, Хуршид, Атамуратов, Бахтиёр, Юлдашов, Бахтиёр, Fozilov , Xurshid, Atamuratov, Baxtiyor, Yuldashov, Baxtiyor, Fozilov, Khurshid, Atamuratov, Bakhtiyor, Yuldashov, Bakhtiyor

O‘zbekiston кardiologiyasi · 2025-yil

Annotatsiya

Aim. To evaluate the efficacy and safety of the Uzbekistan-manufactured “Sinotech+” stent during primary percutaneous coronary intervention (pPCI) in patients presenting with ST-elevation acute coronary syndrome (STEMI). Materials and methods. The study was conducted at the X-ray Endovascular Treatment Department of Cardiovascular Diseases at the RSSPMCC. Between January and June 2025, all 31 patients diagnosed with STEMI underwent pPCI procedures. "Sinotech+" stents were implanted in 17 patients (54.8%), while "Resolute Integrity" stents were implanted in 14 patients (45.2%). Patients who received "Sinotech+" stent implantation were analyzed. Results. Coronary lesion distribution was as follows: single-vessel disease in 5 patients (29.4%), two- vessel disease in 7 patients (41.2%), and multi-vessel disease in 5 patients (29.4%). Pre-procedural coronary flow assessment using the TIMI (Thrombolysis in Myocardial Infarction) perfusion scale revealed TIMI-0 flow in 9 patients (53%) and TIMI-1 flow in 8 patients (47%). Following pPCI, TIMI-3 flow was achieved in 14 patients (82.4%), while TIMI-2 flow was achieved in the remaining 3 patients (17.6%). These results demonstrated 100% technical success (stent deployment and vessel opening) and 82.4% angiographic success (achieving TIMI-3 flow), indicating high clinical efficacy of primary PCI using “Sinotech+” stents. Conclusion. The Uzbekistan-manufactured “Sinotech+” stent demonstrated high efficacy and safety in patients presenting with STEMI. No complications (thrombosis, restenosis, recurrent myocardial infarction, repeat revascularization) were observed during clinical follow-up.

Maqola ma’lumotlari
MualliflarФозилов, Хуршид, Атамуратов, Бахтиёр, Юлдашов, Бахтиёр, Fozilov , Xurshid, Atamuratov, Baxtiyor, Yuldashov, Baxtiyor, Fozilov, Khurshid, Atamuratov, Bakhtiyor, Yuldashov, Bakhtiyor
JurnalO‘zbekiston кardiologiyasi
NashriyotЎзбекистон кардиологлар ассоциацияси
ISSN3060-4850
Nashr sanasi2025-06-30
Jild2
Son2
Betlar110-121
TilIngliz
Ilmiy sohaTibbiyot
DOI10.70626/cardiouz-2025-2-00043
Indeksga qo‘shilgan2026-08-26

DOI: 10.70626/cardiouz-2025-2-00043 · Maqolaning asl sahifasi

Kalit so‘zlar

STEMI, pPCI, “Sinotech+”, TIMI, STEMI, pPCI, “Sinotech+”, TIMI, O’KS-ST, bTOKA, “Sinotech+”, TIMI

Ilmiy soha

Tibbiyot

Iqtibos keltirish

APAФозилов, Хуршид, Атамуратов, Бахтиёр, Юлдашов, Бахтиёр, Fozilov , Xurshid, Atamuratov, Baxtiyor, Yuldashov, Baxtiyor, Fozilov, Khurshid, Atamuratov, Bakhtiyor, & Yuldashov, Bakhtiyor (2025). Short and Medium-term Efficacy and Safety of “Sinotech+” (Uzbekistan) Stent in Primary Stenting for Patients with Acute Coronary Syndrome with ST-Segment Elevation. O‘zbekiston кardiologiyasi, 2(2), 110-121. https://doi.org/10.70626/cardiouz-2025-2-00043
GOST (OAK)Фозилов, Хуршид va b. Short and Medium-term Efficacy and Safety of “Sinotech+” (Uzbekistan) Stent in Primary Stenting for Patients with Acute Coronary Syndrome with ST-Segment Elevation // O‘zbekiston кardiologiyasi. – 2025. – T. 2, № 2. – P. 110-121. – DOI: 10.70626/cardiouz-2025-2-00043.
MLAФозилов, Хуршид, Атамуратов, Бахтиёр, Юлдашов, Бахтиёр, Fozilov , Xurshid, Atamuratov, Baxtiyor, Yuldashov, Baxtiyor, Fozilov, Khurshid, Atamuratov, Bakhtiyor, and Yuldashov, Bakhtiyor. “Short and Medium-term Efficacy and Safety of “Sinotech+” (Uzbekistan) Stent in Primary Stenting for Patients with Acute Coronary Syndrome with ST-Segment Elevation.” O‘zbekiston кardiologiyasi, 2(2), 110-121, 2025. https://doi.org/10.70626/cardiouz-2025-2-00043
ChicagoФозилов, Хуршид, Атамуратов, Бахтиёр, Юлдашов, Бахтиёр, Fozilov , Xurshid, Atamuratov, Baxtiyor, Yuldashov, Baxtiyor, Fozilov, Khurshid, Atamuratov, Bakhtiyor, and Yuldashov, Bakhtiyor. “Short and Medium-term Efficacy and Safety of “Sinotech+” (Uzbekistan) Stent in Primary Stenting for Patients with Acute Coronary Syndrome with ST-Segment Elevation.” O‘zbekiston кardiologiyasi, 2(2), 110-121 (2025). https://doi.org/10.70626/cardiouz-2025-2-00043
HarvardФозилов, Хуршид, Атамуратов, Бахтиёр, Юлдашов, Бахтиёр, Fozilov , Xurshid, Atamuratov, Baxtiyor, Yuldashov, Baxtiyor, Fozilov, Khurshid, Atamuratov, Bakhtiyor, and Yuldashov, Bakhtiyor (2025) ‘Short and Medium-term Efficacy and Safety of “Sinotech+” (Uzbekistan) Stent in Primary Stenting for Patients with Acute Coronary Syndrome with ST-Segment Elevation’, O‘zbekiston кardiologiyasi, 2(2), 110-121. https://doi.org/10.70626/cardiouz-2025-2-00043
BibTeX
@article{article2025,
  title = {Short and Medium-term Efficacy and Safety of “Sinotech+” (Uzbekistan) Stent in Primary Stenting for Patients with Acute Coronary Syndrome with ST-Segment Elevation},
  author = {Фозилов, Хуршид and Атамуратов, Бахтиёр and Юлдашов, Бахтиёр and Fozilov , Xurshid and Atamuratov, Baxtiyor and Yuldashov, Baxtiyor and Fozilov, Khurshid and Atamuratov, Bakhtiyor and Yuldashov, Bakhtiyor},
  journal = {O‘zbekiston кardiologiyasi},
  year = {2025},
  volume = {2},
  number = {2},
  pages = {110-121},
  doi = {10.70626/cardiouz-2025-2-00043},
  url = {https://doi.org/10.70626/cardiouz-2025-2-00043}
}

Boshqa maqola uchun iqtibos tayyorlash

O‘zbekiston кardiologiyasi jurnalidan boshqa maqolalar

O‘zbekiston кardiologiyasi — barcha maqolalar · 2025-yil arxivi

Фозилов, Хуршид — boshqa maqolalari

Tibbiyot sohasidagi boshqa maqolalar

Tibbiyot sohasidagi OAK jurnallari